- March 2025: $71.66 (post-winter consolidation)
- May 2025: $81.00 (Q1 earnings catalyst)
- July 2025: $92.50 (summer momentum build)
- August 2025: $98.00 (current levels near all-time highs)
How to Buy Turning Point Brands, Inc. (TPB) Shares - Investment in Turning Point Brands, Inc. (TPB) Stock
Updated on 29 Aug 2025
Thinking about investing in a company that's redefining the tobacco and alternative products industry? Turning Point Brands (TPB) combines iconic legacy brands with explosive growth in modern oral products—making it a fascinating play for both value and growth investors. With the stock delivering remarkable returns and the company hitting record financial performance, understanding how to buy Turning Point Brands, Inc. (TPB) shares could be your ticket to participating in this unique market transformation.
Article navigation
- 📈 Current Market Position and Entry Strategy
- 🔮 Price Forecast: 2025-2030 Outlook
- ⚠️ Risk Assessment vs. Growth Catalysts
- 🛡️ What Should a Beginner Trader Do Today?
- ✅ How to Buy Turning Point Brands, Inc. (TPB) Shares – Step by Step
- 💡 Why Pocket Option Appeals to New Investors
- 🌍 Turning Point Brands in 2025: Innovation Meets Tradition
📈 Current Market Position and Entry Strategy
As of August 29, 2025, Turning Point Brands (TPB) trades at $98.00 per share, sitting near its all-time high territory after an incredible run throughout 2025. The stock reached its peak of $102.90 on August 14, 2025, demonstrating the strong momentum behind this consumer products company.
Critical Date Alert: Mark your calendar for November 6, 2025—this is when TPB releases its Q3 earnings report. Historically, this company has shown impressive price movements around earnings announcements, with the stock typically gaining 4.4% during the two-week period before earnings releases.
Historical Earnings Impact Analysis
Let’s examine how TPB’s stock has reacted to recent earnings surprises:
| Date | Event | Pre-News Price | Post-News Change |
|---|---|---|---|
| Aug 6, 2025 | Q2 Earnings | $85.20 | +15.3% (beat by $0.19) |
| May 7, 2025 | Q1 Earnings | $78.50 | +16.1% (beat by 21.33%) |
| Feb 2025 | Annual Results | $72.30 | +8.7% (strong guidance) |
The pattern is clear: when TPB beats expectations—which they’ve done consistently in 2025—the stock reacts very positively. Their Q2 2025 performance was particularly impressive, with revenue surging 25.1% year-over-year to $116.6 million and Modern Oral sales exploding by 651% to $30.1 million.
6-Month Price Journey Analysis
TPB has been on an absolute tear over the past six months, delivering one of the most impressive performances in the consumer products sector:
This represents a 36.7% gain over six months, significantly outperforming both the broader market and the tobacco industry average. The stock has shown remarkable consistency, trading well above its 50-day moving average of $83.84 and its 200-day moving average of $68.49.
🔮 Price Forecast: 2025-2030 Outlook
Based on current analyst projections and the company’s explosive growth trajectory, here’s what we can expect:
- 2025 Year-End: $105-115 (continued Modern Oral expansion + holiday sales) → STRONG BUY
- 2026: $90-110 (regulatory normalization + market digestion)
- 2028: $120-140 (market leadership consolidation)
- 2030: $150-180 (global expansion + product innovation)
The near-term outlook remains exceptionally bullish, driven by TPB’s incredible Modern Oral segment growth and strong execution across all business units. However, investors should be aware that some analysts maintain more conservative targets around $73-85, reflecting concerns about regulatory pressures.
⚠️ Risk Assessment vs. Growth Catalysts
Potential Risks to Consider
- Regulatory Headwinds: TPB faces ongoing PMTA compliance costs and potential new regulations that could impact traditional tobacco segments. The Zig-Zag segment already showed a 6.9% sales decline in recent quarters.
- Valuation Concerns: With the stock up over 148% in the past year, some analysts worry about stretched valuations despite strong fundamentals.
- Industry Transformation: The shift away from traditional tobacco products creates uncertainty, though TPB is well-positioned to benefit from this transition.
Positive Signals for 2025
- Explosive Growth: Modern Oral sales up 651% year-over-year—this isn’t just growth, it’s a transformation!
- Record Financials: Q2 net income surged 31.3% to $16.96 million with revenue beating expectations by 10.50%.
- Market Leadership: Products in 215,000+ retail outlets across North America provides incredible distribution reach.
- Strong Guidance: Management raised full-year Adjusted EBITDA guidance to $110-114 million.
🛡️ What Should a Beginner Trader Do Today?
- Dollar-Cost Average: Given the stock’s volatility, consider investing smaller amounts regularly rather than one lump sum.
- Earnings Strategy: Plan around the November 6th earnings date—historical patterns suggest potential opportunities both before and after announcements.
- Sector Allocation: Keep TPB exposure reasonable (5-10% of portfolio max) given the specialized nature of the business.
- Humorous Reality Check: “Trading TPB is like their Modern Oral products—it gives you a quick buzz but requires careful handling to avoid regulatory heartburn!”
✅ How to Buy Turning Point Brands, Inc. (TPB) Shares – Step by Step
| Step | Action | Why It Matters |
|---|---|---|
| 1 | Choose a Trading Platform | Ensure it offers NYSE access (TPB’s exchange) |
| 2 | Complete Account Funding | Start with an amount you’re comfortable risking |
| 3 | Search for “TPB” | Use the ticker symbol, not just the company name |
| 4 | Select Order Type | Use limit orders to control entry price |
| 5 | Review and Execute | Double-check order details before confirming |
💡 Why Pocket Option Appeals to New Investors
For those looking to dip their toes into stock trading, Pocket Option offers several advantages that make starting your investment journey smoother:
- Minimum Deposit: Just $5 lets you begin testing strategies with real market conditions
- Rapid Verification: 1-minute KYC process with any government-issued ID
- Withdrawal Options: Over 100 methods including cryptocurrencies and e-wallets
- User-Friendly Platform: Intuitive interface perfect for learning how markets work
The platform’s low barrier to entry makes it ideal for practicing your investment approach with Turning Point Brands, Inc. (TPB) stock before committing larger amounts.
🌍 Turning Point Brands in 2025: Innovation Meets Tradition
Turning Point Brands operates in the fascinating space where traditional tobacco products meet modern consumer preferences. The company manufactures and distributes branded consumer products including alternative smoking accessories and consumables with active ingredients through their iconic Zig-Zag and Stoker’s brands.
What makes TPB particularly interesting in 2025 is their incredible success in the Modern Oral segment, which grew nearly 10-times year-over-year to become a significant revenue driver. This isn’t just a company selling rolling papers—it’s transforming itself into a modern consumer products powerhouse.
Interesting 2025 Fact: TPB’s Modern Oral products achieved such explosive growth that they nearly doubled from the previous quarter while growing 10-times year-over-year—a rare combination of sequential and annual acceleration that shows truly exceptional product-market fit.
FAQ
What is Turning Point Brands' main business?
TPB manufactures and distributes smoking accessories and consumable products through their Zig-Zag and Stoker's brands, with growing focus on modern oral products.
How often does TPB pay dividends?
The company pays a quarterly dividend, currently at $0.30 per share, demonstrating their commitment to returning value to shareholders.
Is TPB considered a growth stock or value stock?
With 25%+ revenue growth and exploding segment performance, TPB currently behaves more like a growth stock despite its value characteristics.
What are the biggest risks for TPB investors?
Regulatory changes, valuation concerns after big gains, and dependence on the successful scaling of their Modern Oral segment.
How has TPB performed compared to the broader market?
Exceptionally well—up over 148% in the past year compared to roughly 16% for the broader market, though with higher volatility.
Signals
Sign up for more like this
Customize your newsfeed with content you're actually interested in — get up-to-date personalized newsletter in your inbox.
Your comment
Comments are pre-moderated to ensure they comply with our blog guidelines.